Product Images Amoxapine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Amoxapine NDC 0591-5716 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 1

image 1

image 2

image 2

Amoxapine is a medication available in the form of tablets, that contains 25 mg of USP Amoxapine. It is important that a pharmacist dispenses the medication along with a guide for each patient. The package insert contains the full prescribing information along with the dosage. The medicine should be kept in a tight container with child-resistant closure, and stored at a controlled room temperature between 20° to 25°C. The manufacturer is Watson Pharma Private Limited, located in Salcette Goa, India, and the distributor is Actavis Pharma Inc. The code and revision are GO/DRUGS/741 rev.02/15.*

image 3

image 3

Amoxapine is a medication that comes in the form of tablets. Each tablet comprises 50 mg of Amoxapine, USP. The tablets are to be dispensed in a tight container with a child-resistant dosage. The pharmacies must provide the patient with a medication guide separately. The package insert should be referred to for the prescription's dosage and complete product information. The medication needs to be stored between 20°C to 25°C (68°F to 77°F) at controlled room temperature. The packaging company is Watson Pharma Private Limited based in Verna, Salcette Goa in India. Actavis Pharma, Inc in Parsippany, NJ, the USA, distributes it. Lot number 190826-1 has been revised in Feb 2015 (Rev. 02/15).*

image 4

image 4

image 5

image 5

The text describes a medication guide for Amoxapine tablets, USP with a dosage of 150 mg. It is recommended to store it in a tight container with child-resistant closure at 20°C to 25°C. The medication is manufactured by Watson Pharma Private Limited and distributed by Actavis Pharma Inc. It contains NDC0591-5716-30 and code no. GO/DRUGS 741.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.